Diagnosis to Ablation in Persistent AF: Any Time Can Be a Good Time to Ablate

Key Findings:

Results from the CAPLA trial show that patients with shorter Diagnosis-to-Ablation Time (DAT) had lower rates of atrial fibrillation (AF) recurrence after ablation.

Practical Solutions:

Using standardized entry criteria and intensive monitoring, clinicians can identify the optimal timing for ablation in patients with persistent AF, potentially reducing recurrence rates.

Value:

Despite modest differences, all patient groups experienced low AF burden and improved quality of life after ablation, highlighting the overall benefits of the procedure.

AI-Driven Support:

DocSym’s AI-driven platform consolidates clinical standards and research, providing clinicians with a comprehensive knowledge base for informed decision-making.

Streamlined Operations:

Mobile apps from DocSym facilitate scheduling, treatment monitoring, and telemedicine, enabling efficient patient care management and digital service expansion.